awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35212678-F8293AC8-13EF-47BE-9115-9698F127E170
Q35212678-F8293AC8-13EF-47BE-9115-9698F127E170
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35212678-F8293AC8-13EF-47BE-9115-9698F127E170
Sorafenib and dacarbazine as first-line therapy for advanced melanoma: phase I and open-label phase II studies
P2860
Q35212678-F8293AC8-13EF-47BE-9115-9698F127E170
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35212678-F8293AC8-13EF-47BE-9115-9698F127E170
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4fd2789c6dda1a51a4645212864a3e674a7af191
P2860
Optimal two-stage designs for phase II clinical trials.